Joshua Resnick's most recent trade in Sionna Therapeutics Inc. was a trade of 19,959 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sionna Therapeutics Inc. | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 19,959 | 19,959 | - | - | Non-Qualified Stock Option (right to buy) | |
| PepGen Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| PepGen Inc | Joshua Resnick | Director | 20 Jun 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | ||
| Jade Biosciences Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| PepGen Inc | Joshua Resnick | Director | 22 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | ||
| Jade Biosciences Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Jade Biosciences Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 16,911 | 16,911 | - | - | Stock Option (right to buy) | |
| PepGen Inc | Joshua Resnick | Director | 06 May 2022 | 11,667 | 11,667 | - | - | Stock Option (Right to Buy) | ||
| Jade Biosciences Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Vor Biopharma Inc | Joshua Resnick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 16,900 | 16,900 | - | - | Stock Option (right to buy) |